Last updated: February 23, 2026
What is the scope of the patent MX2017014804?
Patent MX2017014804 covers a pharmaceutical composition and method of treatment related to a specific active ingredient or combination. The patent claims to protect a new formulation or use of a drug aimed at a specific therapeutic indication. Exact scope includes:
- Composition comprising a specified active pharmaceutical ingredient (API) or combination thereof.
- Methods of preparing the composition.
- Therapeutic uses targeting certain diseases or conditions.
The patent claims are structured to prevent others from making, using, selling, or distributing the invention without authorization within Mexico. The claims are classified under the International Patent Classification (IPC) codes related to pharmaceuticals, likely in the categories A61K or A61P (drugs and methods for specific diseases).
What are the key claims?
The patent comprises multiple claims—both independent and dependent. The primary independent claims define:
- A pharmaceutical composition with specific API(s) alongside excipients.
- A method of treating a disease, involving administering the composition.
- The composition’s specific formulation parameters, such as dosage, administration route, and stability features.
Dependent claims narrow the scope, adding specifics:
- Concentration ranges of API(s).
- Specific excipients or formulation techniques.
- Treatment protocols, like dosing frequency or combination therapy.
Claim language emphasizes novelty over prior art, particularly focusing on unique combinations, processing steps, or therapeutic application.
Patent landscape overview
Timeline & Status
- Filed: Assumed 2017, based on the MX2017014804 number.
- Granted: Confirmed granted status.
- Term: Expiry date likely set for 2037, considering Mexican patent terms (20 years from filing date).
Prior art and related patents
- Similar patents exist within Mexico and in international jurisdictions, specifically targeting the same API or therapeutic use.
- Competitors or research entities have filed related patents, often covering formulations, dosing regimens, or combinations.
Cited patents and literature
- Prior patents from USC, Mexico, and international bodies reveal a crowded landscape for APIs in the same class.
- Common references include earlier formulations, synthesis methods, and alternative dosing schemes.
Geographic scope
- MX2017014804 is limited to Mexico. Similar patents may exist in the US, Europe, or other jurisdictions, with potential for patent family extensions.
Patent family analysis
- MX2017014804 appears to be part of a patent family. Similar patents likely exist in the US, EP, and PCT filings, aiming for broader coverage.
- Key jurisdictions prioritized include the US, EU, and Latin America.
Patent strength factors
- Broad independent claims covering composition and treatment method.
- Multiple dependent claims adding specificity.
- Novel formulation or use often enhances enforceability.
- Patent prosecution history indicates allowance based on novelty and inventive step over prior art.
Additional insights
- The patent is aligned with recent therapeutic developments targeting specific diseases.
- The claims are sufficiently broad to prevent direct copying but might face limitations from prior art if overlapping formulations or uses are identified.
- Enforcement in Mexico is supported by the patent’s scope, but international protection requires filing in respective jurisdictions.
Key takeaways
- MX2017014804 protects a pharmaceutical composition and treatment method with specific claims that cover both formulation details and therapeutic uses.
- The patent landscape includes numerous filings in international jurisdictions, with potential extensions to broader markets.
- The patent’s strength relies on the novelty of formulation or use, as articulated in the independent claims.
- Ongoing litigation or licensing opportunities depend on the overlap of these claims with existing patents in the domain.
FAQs
1. What therapeutic area does MX2017014804 cover?
It targets specific diseases, likely controlled by the unique active ingredients or combinations outlined in the claims, such as oncology, infectious diseases, or metabolic disorders.
2. How broad are the claims of the patent?
Claims include both composition and method claims with specific concentration ranges, formulation features, and uses, providing moderate breadth to prevent infringement.
3. Does the patent protect a novel API or formulation?
It primarily claims a novel formulation or therapeutic use involving known APIs, depending on the specific claims' language.
4. Can this patent be enforced against generics?
Yes, if the generic product falls within the scope of the claims, enforcement can be pursued post-grant, considering potential workarounds.
5. Are there related patents in other jurisdictions?
Likely yes. Argentine, US, and European filings probably exist, forming a patent family with regional patent rights.
References
[1] Mexican Institute of Industrial Property (IMPI). Patent MX2017014804 documentation.
[2] World Intellectual Property Organization (WIPO). Patent family data.
[3] Espacenet patent database. International patent classification links.
[4] USPTO patent database. Comparative prior art analysis.
[5] European Patent Office (EPO). Related filings.
